TABLE 1.
Participant Characteristics
| Full Study Sample (N = 28) | Intervention Completers (n = 16) | |
|---|---|---|
| Age (years), median (IQR) | 30 (24-45) | 28 (24-39) |
| Male, n (%) | 20 (71.4) | 11 (68.8) |
| Race/ethnicity, n (%) | ||
| White | 8 (28.6) | 4 (25.0) |
| Hispanic | 11 (39.3) | 6 (37.5) |
| African American | 3 (10.7) | 2 (12.5) |
| Native American | 4 (14.3) | 3 (18.8) |
| Other | 2 (7.1) | 1 (6.3) |
| HIV risk factor, n (%) | ||
| MSM | 15 (53.6) | 8 (50.0) |
| Heterosexual contact | 11 (39.3) | 6 (37.5) |
| IDU | 2 (7.1) | 2 (12.5) |
| ART adherence barriers, n (%) | ||
| Previous ART nonadherence | 10 (35.7) | 4 (25.0) |
| Physician referral | 5 (17.5) | 2 (12.5) |
| Previous medication nonadherence | 3 (10.7) | 2 (12.5) |
| Polypharmacy | 1 (3.6) | 1 (6.3) |
| Busy life schedule | 1 (3.6) | 1 (6.3) |
| Active substance abuse | 1 (3.6)) | 1 (6.3) |
| Homelessness | 1 (3.6) | 0 (0.0) |
| > 1 ART adherence barrier | 6 (21.4) | 5 (31.3) |
| Psychiatric diagnoses, n (%) | ||
| Depression | 11 (39.3) | 7 (43.8) |
| Depression and anxiety | 4 (14.3) | 3 (18.8) |
| Depression or anxiety with PTSD | 4 (14.3) | 2 (12.5) |
| Bipolar or other mood disorder | 3 (10.7) | 2 (12.5) |
| No psychiatric diagnosis | 6 (21.4) | 2 (12.5) |
| SAMISS, n (%) | ||
| SA (+)/MH (+) | 7 (25.0) | 4 (25.0) |
| SA (+)/MH (-) | 1 (3.6) | 1 (6.3) |
| SA (-)/MH (+) | 15 (53.6) | 10 (62.5) |
| SA (-)/MH (-) | 5 (17.9) | 1 (6.3) |
| CD4 count (cells/mm3), median (IQR) | 325 (91-435) | 298 (93-427) |
| HIV RNA (copies/mL), median (IQR) | 58,500 (21,250-155,013) | 48,000 (16,750-139,000) |
ART = antiretroviral therapy; HIV = human immunodeficiency virus; IDU = injection drug use; IQR = interquartile range; MH = mental health issues; MSM = men who have sex with men; PTSD = posttraumatic stress disorder; SA = substance abuse; SAMISS = substance abuse and mental illness screener.